Stakeholders have until December 31, 2018 to comment on a significant new set of Medicare Part B payment reform options aimed at lowering drug costs for the Medicare program and its beneficiaries. An Advance Notice of Proposed Rulemaking (ANPRM), published in the Federal Register on October 30, 2018 and available here, outlines plans for a potential International Pricing Index (IPI) Model, which would seek to ensure that the Medicare program pays for certain separately payable Part B drugs and biologicals at prices comparable to other countries. The ANPRM aligns with proposals discussed in a speech by President Trump on October 25, 2018, and with findings set forth in a report released on the same date by the White House Office of the Assistant Secretary for Planning and Evaluation (ASPE).
Sidley Austin LLP provides this information as a service to clients and other friends for educational purposes only. It should not be construed or relied on as legal advice or to create a lawyer-client relationship. Readers should not act upon this information without seeking advice from professional advisers.
Attorney Advertising—Sidley Austin LLP, One South Dearborn, Chicago, IL 60603. +1 312 853 7000. Sidley and Sidley Austin refer to Sidley Austin LLP and affiliated partnerships, as explained at www.sidley.com/disclaimer.
© Sidley Austin LLP